Advertisement
Advertisement

CATX

CATX logo

Perspective Therapeutics, Inc.

2.95
USD
Sponsored
-0.02
-0.67%
Jun 12, 15:59 UTC -4
Closed
exchange

After-Market

3.02

+0.07
+2.34%

Perspective Therapeutics, Inc. Profile

About

Perspective Therapeutics Inc. is a medical technology and radiopharmaceutical company which provide advanced treatment applications for cancers. The Company is the sole producer of Cesium-131 brachytherapy seeds. Perspective Therapeutics Inc., formerly known as Isoray Inc., is based in RICHLAND, Wash.

Info & Links

CEO

Johan Thijs Spoor

Headquarters

2401 ELLIOTT AVENUE, SUITE 320
SEATTLE, WA 98121, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.perspectivetherapeutics.com

Auditor

WithumSmith+Brown, PC

Share holders

62

Employees

166

Perspective Therapeutics, Inc. Statistics

Valuation Measures

Market Capitalization2

344.31M

Enterprise Value

291.94M

Enterprise Value/EBITDA(ttm)

-2.46

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

578.69

Price to Book(mrq)

1.61

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-11813.12%

Profit Margin(ttm)

-28083.73%

Return on Equity(ttm)

-41.79%

Return on Invested Capital(ttm)

-43.58%

Return on Assets(ttm)

-34.76%

Income Statement

Revenue(ttm)

618.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

618.00K

EBITDA(ttm)3

-118.59M

Net Income Available to Common(ttm)

-111.13M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.86

52-Week Change

-10.06%

S&P 500 52-Week Change

22.93%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

114.05M

Dividend Yield

0.00%

Float4

109.69M

% Held by Insiders

3.72%

% Held by Institutions

54.66%

Balance Sheet

Total Cash(mrq)

270.93M

Total Cash Per Share(mrq)

2.38

Total Debt(mrq)

1.61M

Total Debt/Equity(mrq)

0.78%

Current Ratio(mrq)

5.17%

Quick Ratio(mrq)

5.17%

Book Value Per Share(mrq)

2.79

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.12

Free Cash Flow(ytd)

-95.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement